Progesterone prevents depression-like behavior in a model of Parkinson's disease induced by 6-hydroxydopamine in male rats

Pharmacology Biochemistry and Behavior

Volumn 99, Issue 4, 2011, Pages 614-618

  Casas, Sebastián ^a   García, Sebastián ^a   Cabrera, Ricardo ^a   Nanfaro, Federico ^a   Escudero, Carla ^a   Yunes, Roberto ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

6 OHDA; Depression like behavior; Forced swimming test; Hemiparkinsonism; Imipramine; Neuroactive steroids; Parkinson's disease; Progesterone; Steroids

Indexed keywords

AMPHETAMINE; APOMORPHINE; IMIPRAMINE; OXIDOPAMINE; PROGESTERONE;

AFFECTIVE PSYCHOSIS; AMNESIA; ARTICLE; COGNITION; DEPRESSION; DRUG INDUCED DISEASE; MALE; MOTOR DYSFUNCTION; NEUROPROTECTION; NONHUMAN; OPEN FIELD BEHAVIOR; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

AMPHETAMINE; ANIMALS; ANTIDEPRESSIVE AGENTS; APOMORPHINE; CUES; DEPRESSION; DOPAMINE AGONISTS; MALE; MEMORY; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; RECOGNITION (PSYCHOLOGY); STEREOTYPED BEHAVIOR; SWIMMING; SYMPATHOLYTICS;

ANIMALIA; RATTUS;

EID: 79959810595     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.06.012     Document Type: Article

References (42)

1. Ahmad A, Ansari M, Ahmad M, Saleem S, Yousuf S, M Hoda, et al. Neuroprotection by crocetin in a hemi-parkinsonian rat model. Pharmacol, Biochem and Behav 2005;81:805-13. (Pubitemid 41187813)
2. E. Baulieu Neurosteroids: a novel function of the brain Psychoneuroendocrinology 23 1998 963 987 (Pubitemid 29049302)
3. M. Bourque, D. Dluzen, and T. Di Paolo Neuroprotective actions of sex steroids in Parkinson's disease Front Neuroendocrinol 30 2009 142 157
4. I. Branchi, I. D'Andrea, M. Armida, T. Cassano, A. Pèzzola, and R. Potenza Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model J Neurosci Res 86 2008 2050 2061
5. R. Brinton, R. Thompson, M. Foy, M. Baudry, J. Wang, and C. Finch Progesterone receptors: form and function in brain Front Neuroendocrinol 29 2008 313 339
6. S. Callier, M. Morissette, M. Grandbois, D. Pélaprat, and T. Di Paolo Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice Synapse. 41 2001 131 138
7. S. Chen, J. Nilsen, and R. Brinton Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications Endocrinology 147 2006 5303 5313 (Pubitemid 44790585)
8. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909 (Pubitemid 37130207)
9. M. Djebaili, S. Hoffman, and D. Stein Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex Neuroscience 123 2004 349 359 (Pubitemid 38035216)
10. M. Djebaili, Q. Guo, E. Pettus, S. Hoffman, and D. Stein The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats J Neurotrauma 22 2005 106 118
11. A. De Nicola, F. Labombarda, M. Deniselle, S. Gonzalez, L. Garay, and M. Meyer Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration Front Neuroendocrinol 30 2009 173 187
12. E. Dere, J. Huston, and M. De Souza Silva The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents Neurosci Biobehav Rev 31 2007 673 704 (Pubitemid 46670336)
13. A. Ennaceur, and J. Delacour A new one-trial test for neurobiological studies of memory in rats Behav Brain Res 31 1988 47 59
14. C. Estrella, C. Bregonzio, and R. Cabrera Differential responses in central dopaminergic activity induced by apomorphine in IPL nude rat Behav Brain Res 133 2002 143 148 (Pubitemid 34759925)
15. J. Frankel, A. Lees, P.A. Kempster, and G. Stern Subcutaneous apomorphine in the treatment of Parkinson's disease J Neurol Neurosurg Psychiatry 53 1990 96 101 (Pubitemid 20067654)
16. C. Frye Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse Pharmacol Biochem Behav. 86 2007 209 219 (Pubitemid 46282047)
17. C. Frye Steroids, reproductive endocrine function and affect Minerva Ginecol 61 2009 541 562
18. C. Frye Steroids, reproductive endocrine function and cognition Minerva Ginecol 61 2009 563 585
19. C. Frye, S. Petralia, M. Rhodes, and J. DeBold 6-Hydroxydopamine lesions enhance progesterone-facilitated lordosis of rats and hamsters, independent of effects on motor behavior Physiol Behav 99 2010 218 224
20. W. Galpern, L. Burns, T. Deacon, J. Dinsmore, and O. Isacson Xenotransplantion of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology Exp Neurol 140 1996 1 13 (Pubitemid 26266588)
21. L. Garay, M. Deniselle, M. Meyer, J. Costa, A. Lima, and P. Roig Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis Brain Res 1283 2009 177 185
22. D. Gonzalez, O. Miyamoto, T. Touge, K. Sumitani, S. Kuriyama, and T. Itano Unilateral ibotenic acid lesions of the prefrontal cortex reduce rotational behavior in 6-hydroxydopamine-lesioned rats Acta Med Okayama 60 2006 319 324 (Pubitemid 46142086)
23. M. Grandbois, M. Morissette, S. Callier, and T. Di Paolo Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice Neuroreport 11 2000 343 346 (Pubitemid 30074646)
24. S. Hansen, C. Harthon, E. Wallin, L. Löfberg, and K. Svensson The effects of 6-OHDA-induced dopamine depletions in the ventral or dorsal striatum on maternal and sexual behavior in the female rat Pharmacol Biochem Behav 39 1991 71 77
25. M. Hayes, V. Fung, T. Kimber, and J. O'Sullivan Current concepts in the management of Parkinson disease Med J Aust 192 2010 144 149
26. R. Kaur, A. Jaggi, and N. Singh Studies on effect of stress preconditioning in restrain stress-induced behavioral alterations Yakugaku Zasshi 130 2010 215 221
27. L. Kiloh, and J. Ball Depression treated with imipramine: a follow-up study Br Med J 1 1961 168 171
28. J. Kondo, K. Kitamura, M. Inden, and T. Taniguchi Hemiparkinsonian rat models: different sensitivity of dopaminergic neurotoxins International Congress Series 1260 2004 281 285
29. S. Kulkarni, and A. Dhir Effect of various classes of antidepressants in behavioral paradigms of despair Prog. Neuropsychopharmacol Biol Psychiatry 31 2007 1248 1254 (Pubitemid 47081311)
30. C. Larramendy, I. Taravini, M. Saborido, J. Ferrario, M. Murer, and O. Gershanik Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism Behav Brain Res 194 2008 44 51
31. M. Liu, M. Kelley, P. Herson, and P. Hurn Neuroprotection of sex steroids Minerva Endocrinol 35 2010 127 143
32. F. Nanfaro, R. Cabrera, V. Bazzochini, M. Laconi, and R. Yunes Pregnenolone sulfate infused in lateral septum of male rats impairs novel object recognition memory Pharmacol Rep 62 2010 265 272
33. Ottoni E. 2000. EthoLog 2.2: a tool for the transcription and timing of behavior observation sessions. Behav Res Methods Instrum Comput 2000;32:446-9.
34. R. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in rats and mice: strain differences and the effects of imipramine Eur J Pharmacol 51 1978 291 294 (Pubitemid 9208063)
35. R. Rafal, R. Friedman, and M. Lannon Preparation of manual movements in hemiparkinsonism J Neurol, Neurosurg and Psych 52 1989 399 402 (Pubitemid 19075090)
36. K. Saravanan, K. Sindhu, and K. Mohanakumar Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease Brain Res 1049 2005 147 155 (Pubitemid 41072930)
37. R. Savica, W. Rocca, and J. Ahlskog When does Parkinson disease start? Arch Neurol 67 2010 798 801
38. L. Shulman Gender differences in Parkinson's disease Gend Med 4 2007 8 18 (Pubitemid 46917063)
39. S. Singh, D. Hota, A. Prakash, K. Khanduja, S. Arora, and A. Chakrabarti Allopregnanolone, the active metabolite of progesterone protects against neuronal damage in picrotoxin-induced seizure model in mice Pharmacol Biochem Behav 94 2010 416 422
40. M. Tadaiesky, P. Dombrowski, C. Figueiredo, E. Cargnin-Ferreira, C. Cunha, and R. Takahashi Emotional, cognitive and neurochemical alterations in a premotor stage model Parkinson's disease Neuroscience 156 2008 830 840
41. A. Tessitore, A. Russo, M. Cirillo, A. Giordano, L. Marcuccio, and G. Tedeschi Hemiparkinsonism and hemiatrophy syndrome: a rare observation Clin Neurol and Neurosurg 112 2010 524 526
42. J. Veliskova, and S. Moshe Update on the role of substantia nigra pars reticulata in the regulation of seizures Epilepsy Curr. 6 2006 83 87